Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.41% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Insteel Industries
IIIN
$626M
| $797K | ﹤0.01% |
41,800
+6,800
| +19% | +$115K |
|
2227
Bar Harbor Bankshares
BHB
$684M
| $795K | ﹤0.01% |
35,500
+5,800
| +20% | +$108K |
|
2228
BrightView Holdings
BV
$1.09B
| $795K | ﹤0.01% |
71,000
+10,800
| +18% | +$131K |
|
2229
Heritage Insurance Holdings
HRTG
$984M
| $795K | ﹤0.01% |
60,700
+9,100
| +18% | +$107K |
|
2230
Mercer International
MERC
$33.9M
| $795K | ﹤0.01% |
97,372
+15,700
| +19% | +$131K |
|
|
APTS
2231
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $795K | ﹤0.01% |
104,600
+15,800
| +18% | +$115K |
|
|
DHIL
2232
DELISTED
Diamond Hill
DHIL
| $790K | ﹤0.01% |
6,954
+700
| +11% | +$73.3K |
|
2233
Mercantile Bank Corp
MBWM
$1.06B
| $789K | ﹤0.01% |
34,900
+6,600
| +23% | +$145K |
|
|
RC
2234
Ready Capital
RC
$296M
| $789K | ﹤0.01% |
90,745
+16,445
| +22% | +$112K |
|
|
DSPG
2235
DELISTED
DSP Group Inc
DSPG
| $789K | ﹤0.01% |
+49,700
| New | +$815K |
|
2236
Cadiz
CDZI
$297M
| $788K | ﹤0.01% |
+77,600
| New | +$866K |
|
|
VRS
2237
DELISTED
Verso Corporation
VRS
| $787K | ﹤0.01% |
65,800
-1,500
| -2% | -$19.6K |
|
2238
Central Garden & Pet Co
CENT
$2.77B
| $786K | ﹤0.01% |
27,313
+2,125
| +8% | +$57.2K |
|
2239
Hackett Group
HCKT
$278M
| $785K | ﹤0.01% |
57,992
+9,400
| +19% | +$130K |
|
2240
Xenon Pharmaceuticals
XENE
$6.17B
| $784K | ﹤0.01% |
+62,500
| New | +$795K |
|
|
AMRS
2241
DELISTED
Amyris Inc.
AMRS
| $781K | ﹤0.01% |
183,000
+80,700
| +79% | +$268K |
|
|
KE
2242
Kimball Electronics
KE
$610M
| $779K | ﹤0.01% |
57,500
+8,800
| +18% | +$113K |
|
2243
Puma Biotechnology
PBYI
$451M
| $771K | ﹤0.01% |
73,930
+14,400
| +24% | +$149K |
|
2244
Par Pacific Holdings
PARR
$4.1B
| $770K | ﹤0.01% |
85,659
+21,100
| +33% | +$182K |
|
2245
Republic Bancorp
RBCAA
$1.92B
| $769K | ﹤0.01% |
23,500
+3,500
| +18% | +$111K |
|
|
MTSC
2246
DELISTED
MTS Systems Corp
MTSC
| $769K | ﹤0.01% |
43,700
+6,700
| +18% | +$124K |
|
2247
KALA BIO
KALA
$17.8M
| $768K | ﹤0.01% |
+29
| New | +$821K |
|
2248
A10 Networks
ATEN
$1.97B
| $767K | ﹤0.01% |
112,600
+8,300
| +8% | +$55.7K |
|
|
FBM
2249
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $766K | ﹤0.01% |
49,100
+8,000
| +19% | +$101K |
|
2250
Clean Energy Fuels
CLNE
$390M
| $761K | ﹤0.01% |
342,758
+68,500
| +25% | +$138K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.